Greater China
This gives it an edge over traditional Western pharmaceutical giants.
1
Grab's Singapore e-wallet GrabPay reports higher profit in 2025
2
Vietnam tech giant FPT bets on rising AI demand in Thailand
3
Hong Kong eases listing thresholds to draw more IPOs
4
AI shortens drug discovery to around 1 year in China, Insilico CEO says
5
China to tax offshore trusts as Beijing targets overseas wealth
More Stories
Singapore’s Monk’s Hill undergoes restructuring, strategy shift
Allianz to acquire HSBC’s Singapore insurance business in $2b deal
NIIF invests $15m in specialty healthcare chain NU Hospitals
CXMT to list in Shanghai on July 27 after Asia’s biggest IPO this year
ADM Capital raises $48m for climate finance in Indonesia
Singapore
The firm also sees opportunities in the mid-market space in Japan.
Infrastructure as an asset class has typically been generating stable, long-term returns.
The firm’s private wealth AUM hit $17.8 billion by March 31, 2026.
It is also on track to close its second PE Fund.
The fintech sees stablecoins becoming an increasingly visible part of global money movement.
Rest of Asia
President and COO Jonathan Gray says the firm aims to capture entire AI ecosystem.
The global scenario in secondaries is different from what’s happening in Asia.
Yang believes that public markets “will correct for sure.”
Vietnam
Most recently, the impact investor committed $10m to Do Ventures.
